Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...
11 January 2019 GatewayC is an online cancer education platform for primary care. It is designed to support GPs with earlier cancer detection to improve outcomes and experiences for patients. GatewayC works with people affected by cancer to understand how to better...
GatewayC aims to support primary care in the early diagnosis of cancer, to support patient outcomes and experiences. According to the National Cancer Diagnosis Audit, around one quarter of patients have three or more visits to primary care before a referral is made....
Friday 4th September 2020
It’s World Leukaemia Day today.
Are you confident in spotting the early signs of Leukaemia?
Why not brush up on your knowledge and complete our free online Acute Leukaemia – Early Diagnosis and Chronic Leukaemia – Early Diagnosis courses created in collaboration with Leukaemia Care?
Acute leukaemia can progress rapidly, usually requiring immediate treatment. The two most common types of acute leukaemia are acute myeloid leukaemia (AML), most often diagnosed in older people, and acute lymphoblastic leukaemia (ALL) most often diagnosed in younger people.
Both chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) are often picked up incidentally in primary care. This is because presentation of these diseases can be gradual, with most patients with CLL diagnosed after undergoing a routine blood test.
Our courses will support you to:
Find out more:
|
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...
11 January 2019 GatewayC is an online cancer education platform for primary care. It is designed to support GPs with earlier cancer detection to improve outcomes and experiences for patients. GatewayC works with people affected by cancer to understand how to better...
GatewayC aims to support primary care in the early diagnosis of cancer, to support patient outcomes and experiences. According to the National Cancer Diagnosis Audit, around one quarter of patients have three or more visits to primary care before a referral is made....